P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
Rayid Abdulqawi(Alfaisal University), John A. Smith(Cleveland Metropolitan School District), Kimberley Holt(Manchester Academic Health Science Centre), Rachel Dockry(Manchester Academic Health Science Centre), Bruce G. McCarthy, Anthony Ford(Sunesis (United States)), Gary Layton(University of Geneva)
Cited by 488
Related Papers
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
|Circulation|2011|375
Anatomy and Neurophysiology of Cough
|CHEST Journal|2014|283
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
|CHEST Journal|2011|257
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
|Nature Communications|2020|245